What might the future of personalised cancer patient care look like? Meet Linda, a cancer patient in the not-too-distant future. See how her experience – involving things like next-generation sequencing, liquid biopsies, clinical decision support software and fully personalised combination therapies – could evolve to look quite different from today’s cancer patient care.

Progress in cancer care has been accelerating over the past several decades, and we are now traveling firmly in the direction of personalised medicine. The ultimate destination may be a world in which patients receive diagnostic and treatment plans tailored to their specific cancers.

To learn more about Roche’s ongoing innovation in oncology, visit [ Ссылка ].

Subscribe to our YouTube channel now: [ Ссылка ]

Get in touch with us:

[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

For more information and insights visit: [ Ссылка ]

свернуть